Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Ethoxy mansonone G as an anticancer agent in estrogen receptor-positive and endocrine-resistant breast cancer.

Chonsut P, Mahalapbutr P, Pradubyat N, Chavasiri W, Wonganan P, Ketchart W.

J Pharm Pharmacol. 2019 Dec;71(12):1839-1853. doi: 10.1111/jphp.13176. Epub 2019 Oct 6.

PMID:
31588558
2.

Enhanced Solubility and Anticancer Potential of Mansonone G By β-Cyclodextrin-Based Host-Guest Complexation: A Computational and Experimental Study.

Mahalapbutr P, Wonganan P, Charoenwongpaiboon T, Prousoontorn M, Chavasiri W, Rungrotmongkol T.

Biomolecules. 2019 Sep 27;9(10). pii: E545. doi: 10.3390/biom9100545.

3.

Dimeric tetrahydroxanthones from the lichen Usnea aciculifera.

Tuong TL, Aree T, Do LTM, Nguyen PKP, Wonganan P, Chavasiri W.

Fitoterapia. 2019 Sep;137:104194. doi: 10.1016/j.fitote.2019.104194. Epub 2019 Jun 5.

PMID:
31175954
4.

The prominent impairment of liver/intestinal cytochrome P450 and intestinal drug transporters in sepsis-induced acute kidney injury over acute and chronic renal ischemia, a mouse model comparison.

Sukkummee W, Jittisak P, Wonganan P, Wittayalertpanya S, Chariyavilaskul P, Leelahavanichkul A.

Ren Fail. 2019 Nov;41(1):314-325. doi: 10.1080/0886022X.2019.1602054.

5.

Butoxy Mansonone G Inhibits STAT3 and Akt Signaling Pathways in Non-Small Cell Lung Cancers: Combined Experimental and Theoretical Investigations.

Mahalapbutr P, Wonganan P, Chavasiri W, Rungrotmongkol T.

Cancers (Basel). 2019 Mar 28;11(4). pii: E437. doi: 10.3390/cancers11040437.

6.

Cepharanthine combined with 5-fluorouracil inhibits the growth of p53-mutant human colorectal cancer cells.

Unson S, Kongsaden C, Wonganan P.

J Asian Nat Prod Res. 2019 Jan 29:1-16. doi: 10.1080/10286020.2018.1564136. [Epub ahead of print]

PMID:
30693808
7.

Mechanism of Cepharanthine Cytotoxicity in Human Ovarian Cancer Cells.

Payon V, Kongsaden C, Ketchart W, Mutirangura A, Wonganan P.

Planta Med. 2019 Jan;85(1):41-47. doi: 10.1055/a-0706-7503. Epub 2018 Aug 24.

PMID:
30142661
8.

Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1.

Rattanawong A, Payon V, Limpanasittikul W, Boonkrai C, Mutirangura A, Wonganan P.

Oncol Rep. 2018 Jan;39(1):227-238. doi: 10.3892/or.2017.6084. Epub 2017 Nov 9.

PMID:
29138869
9.

Integrin Receptors Play a Key Role in the Regulation of Hepatic CYP3A.

Jonsson-Schmunk K, Wonganan P, Choi JH, Callahan SM, Croyle MA.

Drug Metab Dispos. 2016 May;44(5):758-70. doi: 10.1124/dmd.115.068874. Epub 2016 Feb 11.

10.

Evaluation of the HC-04 cell line as an in vitro model for mechanistic assessment of changes in hepatic cytochrome P450 3A during adenovirus infection.

Wonganan P, Jonsson-Schmunk K, Callahan SM, Choi JH, Croyle MA.

Drug Metab Dispos. 2014 Jul;42(7):1191-201. doi: 10.1124/dmd.113.056663. Epub 2014 Apr 24.

11.

Just getting into cells is not enough: mechanisms underlying 4-(N)-stearoyl gemcitabine solid lipid nanoparticle's ability to overcome gemcitabine resistance caused by RRM1 overexpression.

Wonganan P, Lansakara-P DS, Zhu S, Holzer M, Sandoval MA, Warthaka M, Cui Z.

J Control Release. 2013 Jul 10;169(1-2):17-27. doi: 10.1016/j.jconrel.2013.03.033. Epub 2013 Apr 6.

12.

The effect of the acid-sensitivity of 4-(N)-stearoyl gemcitabine-loaded micelles on drug resistance caused by RRM1 overexpression.

Zhu S, Wonganan P, Lansakara-P DS, O'Mary HL, Li Y, Cui Z.

Biomaterials. 2013 Mar;34(9):2327-39. doi: 10.1016/j.biomaterials.2012.11.053. Epub 2012 Dec 20.

13.

Microneedle-mediated transcutaneous immunization with plasmid DNA coated on cationic PLGA nanoparticles.

Kumar A, Wonganan P, Sandoval MA, Li X, Zhu S, Cui Z.

J Control Release. 2012 Oct 28;163(2):230-9. doi: 10.1016/j.jconrel.2012.08.011. Epub 2012 Aug 19.

14.

Silencing of ribonucleotide reductase subunit M1 potentiates the antitumor activity of gemcitabine in resistant cancer cells.

Wonganan P, Chung WG, Zhu S, Kiguchi K, Digiovanni J, Cui Z.

Cancer Biol Ther. 2012 Aug;13(10):908-14. doi: 10.4161/cbt.20843. Epub 2012 Aug 1.

15.

Species differences in the pharmacology and toxicology of PEGylated helper-dependent adenovirus.

Wonganan P, Clemens CC, Brasky K, Pastore L, Croyle MA.

Mol Pharm. 2011 Feb 7;8(1):78-92. doi: 10.1021/mp100216h. Epub 2010 Sep 23.

16.

PEGylated Adenoviruses: From Mice to Monkeys.

Wonganan P, Croyle MA.

Viruses. 2010 Feb;2(2):468-502. doi: 10.3390/v2020468. Epub 2010 Feb 1.

17.

Drug-virus interaction: effect of administration of recombinant adenoviruses on the pharmacokinetics of docetaxel in a rat model.

Wonganan P, Zamboni WC, Strychor S, Dekker JD, Croyle MA.

Cancer Gene Ther. 2009 May;16(5):405-14. doi: 10.1038/cgt.2008.99. Epub 2008 Dec 26.

18.
19.

Influence of method of systemic administration of adenovirus on virus-mediated toxicity: focus on mortality, virus distribution, and drug metabolism.

Boquet MP, Wonganan P, Dekker JD, Croyle MA.

J Pharmacol Toxicol Methods. 2008 Nov-Dec;58(3):222-32. doi: 10.1016/j.vascn.2008.07.003. Epub 2008 Aug 3.

20.

Controlled inactivation of recombinant viruses with vitamin B2.

Callahan SM, Wonganan P, Obenauer-Kutner LJ, Sutjipto S, Dekker JD, Croyle MA.

J Virol Methods. 2008 Mar;148(1-2):132-45. Epub 2007 Dec 21.

Supplemental Content

Loading ...
Support Center